Artemisinin based Combination therapy Trial
Not Applicable
- Conditions
- Malaria
- Registration Number
- PACTR201803003018369
- Lead Sponsor
- aboratorios SALVAT, S.A.,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
Inclusion criteria were: older than or equal to six months, with an axillary temperature of ¿ 37°Celcius or history of fever within 24 hours prior enrollment, being resident of Doneguebougou and Torodo since six months, able to take oral treatment, a parasitemia between 1000 and 100,000 asexual Plasmodium falciparum/¿l of blood, having QTc ¿ 450 msec, to sign an informed written consent and to have not used any ACTs components within 28 days before enrollment.
Exclusion Criteria
Patients were excluded if they had symptoms or signs of severe malaria, were unable to take oral medication, had an allergy to one of the study drugs or were pregnant (detected with a urine beta-human chorionic gonadotropin test).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adequate Clinical and Parasitological Response
- Secondary Outcome Measures
Name Time Method Anemia clearance